EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.

J Cancer Res Clin Oncol · 2021 · PMC8236477 · PMID 34003366

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

showed a trendp = 0.14not close (p > 0.1)

Due to the small samples size of the analyzed cohort, the results were not statistically significant; however, patients with both T0 and T1 EGFR mutations showed a trend for worse progression-free survival compared to patients without EGFR mutations detected on ctDNA ( p = 0.14, Log-Rank Test).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.